Colorectal Large-Cell Neuroendocrine Carcinoma: Case Report and Literature Review for Potential Novel Therapeutic Options

Clin Colorectal Cancer. 2020 Mar;19(1):61-64. doi: 10.1016/j.clcc.2019.10.005. Epub 2019 Oct 31.

Authors

Xiaoyi Chen¹, Xiaoyang Wang¹, Maria Abadi², Abhishek Kumar³

Affiliations

¹ Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY.
² Department of Pathology, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY.
³ Department of Hematology/Oncology, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY. Electronic address: kumara20@nychhc.org.

PMID: 31761668
DOI: 10.1016/j.clcc.2019.10.005

No abstract available

Keywords: Bevacizumab; Chemotherapy; Everolimus; Immunotherapy; Targeted therapy.

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / pharmacology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Neuroendocrine / complications
Carcinoma, Neuroendocrine / diagnosis*
Carcinoma, Neuroendocrine / secondary
Carcinoma, Neuroendocrine / therapy
Chemotherapy, Adjuvant / methods
Clinical Trials as Topic
Colectomy
Colon / diagnostic imaging
Colon / pathology
Colon / surgery
Colorectal Neoplasms / complications
Colorectal Neoplasms / diagnosis*
Colorectal Neoplasms / pathology
Colorectal Neoplasms / therapy
Female
Humans
Immune Checkpoint Inhibitors / therapeutic use
Intestinal Perforation / etiology*
Intestinal Perforation / surgery
Liver / diagnostic imaging
Liver Neoplasms / diagnosis*
Liver Neoplasms / secondary
Lung / diagnostic imaging
Lung Neoplasms / diagnosis*
Lung Neoplasms / secondary
Middle Aged
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use
Tomography, X-Ray Computed

Substances

Immune Checkpoint Inhibitors
Protein Kinase Inhibitors